Extended Adjuvant Endocrine Therapy: The Role of Genomic Profiling

Extended Adjuvant Endocrine Therapy: The Role of Genomic Profiling

Episodes

Specialty:

All

Year:

All

EP. 1: Treatment for Early-Stage ER+ Breast Cancer

October 24th 2016

EP. 2: MA.17R Trial Data Results

October 24th 2016

EP. 3: MA.17R Trial Data Effect on Treatment of ER+ Disease

October 24th 2016

EP. 4: Risk of Early Versus Late Recurrence

October 24th 2016

EP. 5: Extended Aromatase Inhibitor Risk/Benefit

October 24th 2016

EP. 6: QOL Analysis of MA.17R and Treatment Decisions

October 24th 2016

EP. 7: Genomic Testing for Risk of Late Recurrence/ASCO Guidelines

October 24th 2016

EP. 8: Types of Genomic Testing

October 24th 2016

EP. 9: Benefits of Genomic Testing in Breast Cancer

October 24th 2016

Trending on OncLive

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer

Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer

European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma